Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.68 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.68 |
| ▸ | RECQL | P46063 | 1/20 | 0.68 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.68 |
| ▸ | LMNA | P02545 | 1/20 | 0.67 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.67 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.67 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.67 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.67 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.67 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.67 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.67 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.67 |
| ▸ | MAOB | P27338 | 9/20 | 0.66 |
| ▸ | APP | P05067 | 1/20 | 0.66 |
| ▸ | GAA | P10253 | 1/20 | 0.64 |
| ▸ | MAPT | P10636 | 1/20 | 0.64 |
| ▸ | MAOA | P21397 | 1/20 | 0.64 |
| ▸ | RAB9A | P51151 | 1/20 | 0.64 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.64 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11840257 | 0.92 | MAOB (0.62) | MEN1ALDH1A1RECQLKMT2ALMNA | |
| SCHEMBL6927496 | 0.91 | MAOB (0.66) | MEN1ALDH1A1RECQLKMT2ALMNA | |
| 4-Benzyloxyaniline SCHEMBL5571271 | 0.91 | MAOB (0.83) | MEN1ALDH1A1RECQLKMT2ALMNA | |
| SCHEMBL1465278 | 0.89 | KMT2A (0.70) | MEN1ALDH1A1RECQLKMT2ALMNA | |
| SCHEMBL27854180 | 0.89 | MEN1 (0.57) | MEN1ALDH1A1RECQLKMT2ALMNA | |
| SCHEMBL27550091 | 0.89 | MAOB (0.80) | MAOBAPPRAB9ANR4A2 | |
| SCHEMBL339813 | 0.89 | LMNA (0.82) | LMNACYP1A2PTGS1SLC6A2CYP2C19 | |
| SCHEMBL27367676 | 0.89 | LMNA (0.82) | LMNACYP1A2PTGS1SLC6A2CYP2C19 | |
| SCHEMBL21993643 | 0.88 | GSTP1 (0.63) | MEN1ALDH1A1RECQLKMT2ALMNA | |
| SCHEMBL11852684 | 0.88 | MAOB (0.62) | MEN1ALDH1A1RECQLKMT2ALMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 55 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117362236-B | Synthesis method of flumazenil | 江苏远恒药业有限公司 | 2024-05-03 | — | — | CN | claimed |
| CN-117362236-A | Synthesis method of flumazenil | 江苏远恒药业有限公司 | 2024-01-09 | — | — | CN | claimed |
| US-20090023075-A1 | Nonaqueous electrolyte including Diphenyl ether and lithium secondary battery using thereof | PANAX ETEC CO., LTD (KR) | 2009-01-22 | — | — | US | claimed |
| EP-1979978-A1 | NONAQUEOUS ELECTROLYTE INCLUDING DIPHENYL ETHER AND LITHIUM SECONDARY BATTERY USING THEREOF | Cheil Industries Inc. (KR) | 2008-10-15 | — | — | EP | claimed |
| WO-2007081151-A1 | NONAQUEOUS ELECTROLYTE INCLUDING DIPHENYL ETHER AND LITHIUM SECONDARY BATTERY USING THEREOF | CHEIL INDUSTRIES INC. (KR) | 2007-07-19 | — | — | WO | claimed |
| CN-117362236-B | Synthesis method of flumazenil | 江苏远恒药业有限公司 | 2024-05-03 | — | — | CN | disclosed |
| CN-117362236-B | Synthesis method of flumazenil | 江苏远恒药业有限公司 | 2024-05-03 | — | — | CN | disclosed |
| CN-117362236-A | Synthesis method of flumazenil | 江苏远恒药业有限公司 | 2024-01-09 | — | — | CN | disclosed |
| CN-117362236-A | Synthesis method of flumazenil | 江苏远恒药业有限公司 | 2024-01-09 | — | — | CN | disclosed |
| CN-115806525-B | Method for synthesizing alpha-triarylamine | 深圳湾实验室 | 2023-05-23 | — | — | CN | disclosed |
| WO-2019111980-A1 | CYCLOALKYLACETIC ACID-TYPE DIAMIDE DERIVATIVE | 第一三共株式会社 | 2019-06-13 | — | — | WO | disclosed |
| US-20170342324-A1 | BIMESOGENIC COMPOUNDS AND MESOGENIC MEDIA | MERCK PATENT GMBH (DE) | 2017-11-30 | — | — | US | disclosed |
| US-20070135600-A1 | Transition metal complex ligand and olefin polymerization catalyst containing transition metal complex | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2007-06-14 | — | — | US | disclosed |
| CN-1649820-A | Compounds that modulate PPAR activity and methods for preparing the same | WARNER LAMBERT CO (US) | 2005-08-03 | — | — | CN | disclosed |
| EP-1175408-A1 | PYRIMIDINONE COMPOUNDS | SMITHKLINE BEECHAM PLC (GB) | 2002-01-30 | — | — | EP | disclosed |
| WO-2000066567-A1 | PYRIMIDINONE COMPOUNDS | SMITHKLINE BEECHAM PLC (GB) | 2000-11-09 | — | — | WO | disclosed |
| CN-87105707-A | Desinsection and the alkane and the alkoxy derivatives alkane that kill mite | — | 1988-03-09 | — | — | CN | disclosed |
| EP-0009787-B2 | PROCESS FOR THE MONOHALOGENATION OF ALKYLBENZENES IN ALPHA POSITION | BAYER AG (DE) | 1986-07-09 | — | — | EP | disclosed |
| EP-0009787-B1 | PROCESS FOR THE MONOHALOGENATION OF ALKYLBENZENES IN ALPHA POSITION | BAYER AG (DE) | 1982-01-13 | — | — | EP | disclosed |
| EP-0009787-A2 | Process for the monohalogenation of alkylbenzenes in alpha position | BAYER AG (DE) | 1980-04-16 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070135600-A1 | Transition metal complex ligand and olefin polymerization catalyst containing transition metal complex | AP1M1, OR10J3, AP2M1 | MEN1 609/4885ALDH1A1 4017/4885RECQL 1984/4885 |
| US-20170342324-A1 | BIMESOGENIC COMPOUNDS AND MESOGENIC MEDIA | MTX1, S100A11, MCRS1 | MEN1 7/4885ALDH1A1 3730/4885RECQL 1260/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.